CAS: 1240529-26-3 - 1,4-Benzodioxin-5-methanamine, 2,3-dihydro-, hydrochloride (1:2)
Fórmula:C9H11NO2.2ClH
InChI:InChI=1S/C9H11NO2.2ClH/c10-6-7-2-1-3-8-9(7)12-5-4-11-8;;/h1-3H,4-6,10H2;2*1H
Clave InChI:InChIKey=TVHPRBWRLRJJDT-UHFFFAOYSA-N
SMILES:Cl.O1C2=CC=CC(=C2OCC1)CN
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 1,4-Benzodioxin-5-methanamine, 2,3-dihydro-, hydrochloride (1:2) REF: AN-AG000LGKCAS: 1240529-26-3 | - - - | A consultar | Mar 04 Jun 24 |
 | 2,3-Dihydro-1,4-benzodioxin-5-ylmethanamine dihydrochloride REF: 3D-QZB52926CAS: 1240529-26-3 | Min. 95% | A consultar | Mar 16 Jul 24 |
1,4-Benzodioxin-5-methanamine, 2,3-dihydro-, hydrochloride (1:2)
CAS:1240529-26-3
Fórmula:
C9H13Cl2NO2
Peso molecular:
238.1110
Ref: AN-AG000LGK
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 4 de Junio de 2024
2,3-Dihydro-1,4-benzodioxin-5-ylmethanamine dihydrochloride
CAS:1240529-26-3
2,3-Dihydro-1,4-benzodioxin-5-ylmethanamine dihydrochloride is a conformationally restricted analog of the neurotransmitter dopamine. It has a methyl …
Fórmula:
C9H13Cl2NO2
Pureza:
Min. 95%
Peso molecular:
238.11 g/mol
Ref: 3D-QZB52926
| 1g | A consultar | |
| 5g | A consultar | |
| 100mg | A consultar | |
| 250mg | A consultar | |
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 16 de Julio de 2024
